$CRY News

Last published 6mo ago

6mo agoCRY XEYGraniteShares Expands YieldBOOST(TM) Lineup with Launch of CRY and XEY ETFsGlobeNewswireNew YieldBOOST TM ETFs Tied to Circle Internet Group and Ether NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- GraniteShares, an ETF issuer specializing in high-conviction and income-oriented ETFs, today announced the
4y agoCRYCryoLife Announces Corporate Rebranding and Changes Name to ArtivionPR NewswireATLANTA, Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from
4y agoCRY SYNHPERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection - NCT05174767ClinicalTrials.govPrimary Endpoint
5y agoCRYCryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services ForumPR NewswireATLANTA, Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-one meetings at the upcoming Canaccord Genuity MedTech
5y agoCRYCryoLife Reports Third Quarter 2021 Financial ResultsPR NewswireATLANTA, Nov. 4, 2021 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in
5y agoCRYCryolife Inc (CRY) Q3 2021 Earnings Call TranscriptEarnings Call TranscriptsCRY earnings call for the period ending September 30, 2021.
5y agoCRYCryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial ResultsPR NewswireATLANTA, Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results will be released on Thursday, November 4, 2021 after
5y agoCRYAnthony Semedo Joins CryoLife Board of DirectorsPR NewswireATLANTA, Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021.
5y agoCRYCryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare ConferencePR NewswireATLANTA, Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19th Annual Global Healthcare Conference o
5y agoCRYCryoLife to Participate in Upcoming Virtual Investor ConferencesPR NewswireATLANTA, Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences.
5y agoCRYCryoLife Reports Second Quarter 2021 Financial ResultsPR NewswireATLANTA, July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million i
5y agoCRYCryolife Inc (CRY) Q2 2021 Earnings Call TranscriptEarnings Call TranscriptsCRY earnings call for the period ending June 30, 2021.
5y agoBAX CRYCryoLife Announces Sale of PerClot to BaxterPR NewswireATLANTA, July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerClot product line to a subsidiary of Baxter Internationa
5y agoBAX CRYBaxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery PortfolioBusiness WireMarks Baxter's entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Baxter International Inc. (NYSE:BAX), a leading global medical products company, ann
5y agoCRYCryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial ResultsPR NewswireATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results will be released on Thursday, July 29, 2021 after the
5y agoCRYCryoLife to Participate in the UBS Global Healthcare Virtual ConferencePR NewswireATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS Global Healthcare Virtual Conference on Tuesday, May
5y agoCRYCryolife Inc (CRY) Q1 2021 Earnings Call TranscriptEarnings Call TranscriptsCRY earnings call for the period ending March 31, 2021.
5y agoCRYCryoLife Reports First Quarter 2021 Financial ResultsPR NewswireATLANTA, April 29, 2021 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $71.1 million
5y agoCRYCryoLife, Inc. to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / April 29, 2021 / CryoLife, Inc. (NYSE:CRY) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 29, 2021 at 4:30 PM Eastern Time. To listen to the event live or access a repl
5y agoCRYCryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial ResultsPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021...
5y agoCRYCryoLife to Participate in 20th Annual Needham Virtual Healthcare ConferencePR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...
5y agoCRYCryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare ConferencePR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...
5y agoCRYCryolife Inc (CRY) Q4 2020 Earnings Call TranscriptEarnings Call TranscriptsCRY earnings call for the period ending February 12, 2021.
5y agoCRYCryoLife Reports Fourth Quarter and Full Year 2020 Financial ResultsPR NewswireFourth Quarter and Recent Business Highlights: Achieved total revenues of $67.9 million in the fourth quarter 2020 versus $69.7 million in the fourth ...
5y agoCRYCryoLife Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2020 Financial ResultsPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full...
5y agoCRYCryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020PR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for ...
6y agoCRYCryoLife Reports Third Quarter 2020 Financial ResultsPR NewswireThird Quarter and Recent Business Highlights: Achieved total revenues of $65.1 million in the third quarter 2020 versus $67.9 million in the third...
6y agoCRYCryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial ResultsPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter...
6y agoCRYCryoLife to Present at the 18th Annual Morgan Stanley Global Healthcare ConferencePR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the ...
6y agoCRYCryoLife Acquires Ascyrus MedicalPR NewswireCryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has...
6y agoCRYCryoLife to Participate in Upcoming Virtual Investor ConferencesPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two ...
6y agoCRYCryoLife Reports Second Quarter 2020 Financial ResultsPR NewswireSecond Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2020 versus $71.1 million in the second ...
6y agoCRYCryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial ResultsPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter...
6y agoCRYCryoLife Announces Pricing of $100 Million Convertible Senior Notes OfferingPR NewswireCryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced...
6y agoCRYCryoLife Announces Offering of Convertible Senior Notes Due 2025PR NewswireCryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced...
6y agoCRYCryoLife Initiates Enrollment in PROACT Xa Clinical TrialPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has initiated...
6y agoCRYCryoLife Reports First Quarter 2020 Financial ResultsPR NewswireFirst Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 2020 versus preliminary first quarter...
6y agoCRYCryoLife Announces Release Date and Teleconference Call Details for 2020 First Quarter Financial ResultsPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 first quarter...
6y agoCRYCryoLife Provides Business Update in Response to COVID-19 PandemicPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has taken multiple steps to...
6y agoCRYCryoLife Receives CE Mark for On-X® Ascending Aortic ProsthesisPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the ...
6y agoCRYCryoLife Reports Fourth Quarter and Full Year 2019 Financial ResultsPR NewswireFourth Quarter and Recent Business Highlights: Total revenues were $69.7 million in the fourth quarter of 2019, reflecting year over year growth of...
6y agoCRYCryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial ResultsPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and...
6y agoLIVN BSX EW CRY+2Aortic Valve Market by Product, by Procedure, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023PR NewswireAortic Valve Market by Product (Valve Type [Tissue/Biological, Mechanical], Suture Type [Sutured, Sutureless]), by Procedure (Minimally Invasive...
6y agoCRYCryoLife Receives FDA Authorization to Commence PROACT Xa Clinical TrialPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received...
6y agoCRY MSONCryoLife and Misonix Enter Into Distribution Agreement for NeoPatchPR NewswireCryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered ...
6y agoCRYCryoLife Receives CE Mark for E-nya Thoracic Stent GraftPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today it has received CE Mark for the ...
6y agoCRYCryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent GraftPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has received CE Mark...
7y agoCRYCryoLife Reports Third Quarter 2019 Financial ResultsPR NewswireThird Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5%...
7y agoCRYCryoLife Announces Release Date and Teleconference Call Details for 2019 Third Quarter Financial ResultsPR NewswireCryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 third quarter...
7y agoANGO CRYAccelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech FundPR NewswireAccelmed, a group of funds investing in healthtech companies in the fields of medical device and digital health, announced today that it is...